Syngene International Stock Screener | Share Price & Fundamental Analysis

Share Price NSE
₹442.70
▲ 4.50 (1.03%)
2026-02-20 00:00:00
Share Price BSE
₹442.60
▲ 4.25 (0.97%)
2026-02-20 00:00:00
Track Syngene International share price live with TickJournal's free stock screener. Analyze Syngene International share price history trends and compare 52-week high low levels. Calculate SYNGENE stock fair value using fundamental analysis and view live share price charts. Determine Syngene International share intrinsic value and compare it with current SYNGENE share price. Record your Syngene International trades in TickJournal's free trading journal and track your portfolio performance.
EPS (TTM) ₹12.35
Dividend Yield 0.29%
Debt to Equity 0.13
Syngene International 52 Week Low ₹432.90
Operating Margin 34.00%
Profit Margin 17.65%
SYNGENE Revenue (TTM) ₹1,037.00
EBITDA ₹363.00
Net Income ₹183.00
Total Assets ₹6,796.00
Total Equity ₹4,727.00

Syngene International Share Price History - Stock Screener Chart

Screen SYNGENE historical share price movements with interactive charts. Analyze price trends and patterns.

Syngene International Company Profile - Fundamental Screener

Screen Syngene International company fundamentals and business profile. Use our stock screener to analyze sector, industry, and key company metrics for SYNGENE shares.
Syngene International Limited is an integrated research, development, and manufacturing services company headquartered in India. It serves global pharmaceutical, biotechnology, nutrition, animal health, consumer goods, and specialty chemical sectors. The company operates across four business divisions: Discovery Services, Development Services, Manufacturing Services, and Dedicated Centers. With approximately 6000 scientists, Syngene...more
Sector Healthcare
Industry Healthcare Technology
Sub-Sector Healthcare Technology
Segment E
Chairperson/CEO Kiran Mazumdar Shaw
ISIN INE398R01022

Syngene International Balance Sheet Screener

Screen SYNGENE balance sheet fundamentals including assets, liabilities, and equity. Use our screener tool to analyze financial health and share price valuation metrics.
Item 2025 2024 2023 2022 2021 2020 2019 2018
Assets
Total Assets 6,796 6,152 5,831 5,564 4,883 4,163 3,704 3,189
Current Assets 2,287 1,959 2,425 2,206 1,807 1,613 1,764 1,720
Fixed Assets 2,802 2,850 2,667 2,393 2,201 2,020 1,377 1,030
Liabilities
Total Liabilities 6,796 6,152 5,831 5,564 4,883 4,163 3,704 3,189
Current Liabilities 673 750 1,025 1,037 929 448 607 685
Non-Current Liabilities 0 0 0 0 0 0 0 0
Shareholders' Equity
Total Equity 4,727 4,258 3,618 3,298 2,821 2,176 1,968 1,720
Share Capital 403 402 401 401 400 400 200 200
Reserves & Surplus 4,324 3,856 3,217 2,897 2,421 1,776 1,768 1,520

Syngene International Income Statement Screener - Profit & Revenue Analysis

Screen Syngene International income statement and profit fundamentals. Analyze SYNGENE quarterly results, revenue growth, EBITDA, net profit margins, and EPS using TickJournal's fundamental screener for Syngene International share price evaluation.
Item 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec 2023-Mar 2023-Jun 2023-Sept 2023-Dec 2022-Mar 2022-Jun 2022-Sept
Revenue 1,037 892 926 933 933 840 908 962 1,017 832 932 883 773 660 784
Expenses 674 668 711 779 600 620 646 660 680 596 663 626 508 472 552
EBITDA 363 224 215 154 333 220 261 302 337 236 268 257 265 188 232
Operating Profit % 34.00% 24.00% 22.00% 15.00% 35.00% 22.00% 27.00% 30.00% 32.00% 26.00% 27.00% 27.00% 33.00% 27.00% 28.00%
Depreciation 106 111 117 114 111 107 111 109 96 102 105 108 80 86 90
Interest 16 12 13 12 13 12 13 12 10 11 13 11 6 9 12
Profit Before Tax 241 101 85 28 209 101 137 181 231 123 151 138 179 93 130
Tax 57 15 18 13 20 26 31 50 52 30 34 27 31 19 28
Net Profit 183 87 67 15 189 76 106 131 179 93 117 112 148 74 102
EPS 4.56 2.16 1.67 0.37 4.70 1.89 2.64 3.27 4.36 2.33 2.90 2.78 3.71 1.85 2.55

Syngene International Cash Flow Screener - Liquidity Fundamentals

Screen SYNGENE cash flow statements and liquidity fundamentals. Analyze operating, investing, and financing activities using our stock screener for share price strength assessment.
Item 2025-March 2024-March 2023-March 2022-March 2021-March 2020-March 2019-March 2018-March
Operating Activities 1,168 1,042 824 581 701 677 630 446
Investing Activities -744 -495 -653 -611 -629 -424 -646 -349
Financing Activities -142 -551 -343 -31 58 -226 -72 -79
Net Cash Flow 281 -4 -172 -62 130 28 -88 18

Syngene International Shareholding Pattern Screener

See Syngene International shareholding pattern with promoter, FII, and DII holdings. Check Syngene International promoter holding and ownership changes for SYNGENE on TickJournal.
Item 2025-Mar 2025-Jun 2025-Sept 2025-Dec 2024-Mar 2024-Jun 2024-Sept 2024-Dec
Promoter Holding 52.74% 52.68% 52.68% 52.68% 54.79% 54.72% 54.72% 52.74%
FII Holding 19.47% 16.50% 16.31% 14.96% 20.92% 20.63% 20.72% 20.64%
DII Holding 21.50% 24.05% 24.62% 25.84% 15.80% 16.80% 17.48% 19.53%
Govt Holding 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Public Holding 5.08% 5.59% 5.28% 5.37% 6.45% 6.08% 5.45% 5.59%
Other Holding 1.21% 1.18% 1.10% 1.15% 2.03% 1.77% 1.62% 1.50%
Shareholder Count 125,090 142,310 136,061 131,750 115,850 120,018 107,338 128,806

Syngene International Share Dividend Screener - Share Yield Analysis

Check Syngene International dividend history with payout and yield data. View Syngene International dividend details including ex-dates and amounts for SYNGENE stock.
Period Dividend Per Share Dividend Yield
2026-March ₹0.00 0.00%
2025-March ₹1.25 0.29%
2024-March ₹1.25 0.17%
2023-March ₹1.25 0.18%
2022-March ₹1.00 0.17%
2021-March ₹0.00 0.00%
2020-March ₹0.00 0.00%
2019-March ₹0.50 0.21%
2018-March ₹1.00 0.34%
2017-March ₹1.00 0.33%

Syngene International Market Events Screener - Corporate Actions

Get Syngene International corporate actions including splits, bonuses, and buybacks. Check Syngene International stock events that may affect SYNGENE share price.
Announcement Date Record Date Event Type Information Price Impact
2026-01-22 2026-01-22 Quarterly Result Announcement NA -8.51%
2025-11-05 2025-11-05 Quarterly Result Announcement NA 2.52%
2025-07-23 2025-07-23 Annual General Meeting NA -8.05%
2025-07-23 2025-07-23 Quarterly Result Announcement NA 6.63%
2025-06-27 2025-06-27 Dividend ₹ 1.25 /share -12.18%
2025-04-23 2025-04-23 Quarterly Result Announcement NA 5.45%
2025-01-23 2025-01-23 Quarterly Result Announcement NA -3.68%
2024-10-23 2024-10-23 Quarterly Result Announcement NA -5.14%
2024-07-24 2024-07-24 Annual General Meeting NA 8.09%
2024-06-28 2024-06-28 Dividend ₹ 1.25 /share 1.73%
2023-06-30 2023-06-30 Dividend ₹ 0.50 /share 21.36%
2023-06-30 2023-06-30 Dividend ₹ 0.75 /share 21.36%
2022-06-30 2022-07-01 Dividend ₹ 0.50 /share -11.59%
2022-06-30 2022-07-01 Dividend ₹ 0.50 /share -11.59%
2019-06-11 2019-06-12 Bonus 1:1 -1.09%

Syngene International Competitors Screener - Peer Comparison

Screen SYNGENE competitors and compare share prices across peer stocks. Use our screener to analyze sector peers, fundamentals, and relative performance for better stock selection.
Company Market Cap P/E Ratio Revenue YoY Growth Net Profit RSI
Syngene International 17,532 49.77 3,714 3.77% 496 17.32
Indegene 11,872 25.91 2,947 10.53% 407 42.93
Suven Life Sciences 3,450 -12.55 18 -46.34% -161 46.51
Vimta Labs 2,184 34.07 322 0.22% 41 44.03
Take Solutions 699 423.09 10 126.67% 1 64.02
Bilcare 153 -3.75 807 4.78% -56 39.40
Jeevan Scientific Technology 111 -53.61 48 17.87% 0 64.76
Adeshwar Meditex 30 33.09 84 5.00% 2 25.68
Vanta Bioscience 14 -1.06 2 -78.57% -13 14.41

Syngene International Company Announcements - News Screener

Screen SYNGENE latest company announcements and news updates. Filter stock news, results, and material events using our screener for share price impact analysis.
Date Update Actions
2026-02-20 Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 View
2026-02-20 Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 View
2026-02-20 Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 View
2026-02-12 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2026-01-30 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2026-01-29 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome View
2026-01-29 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2026-01-28 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2026-01-24 Announcement under Regulation 30 (LODR)-Newspaper Publication View
2026-01-23 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome View
2026-01-23 Announcement under Regulation 30 (LODR)-Investor Presentation View
2026-01-22 Board Comments On Fine Levied By The Exchanges. View
2026-01-22 Intimation Of Amendment Of Code Of Practices And Procedures For Fair Disclosure Of Unpublished Price Sensitive Information (UPSI) Of The Company. View
2026-01-22 Board Meeting Outcome for Outcome Of The Board Meeting - January 22 2026. View
2026-01-22 Announcement under Regulation 30 (LODR)-Press Release / Media Release View
2026-01-22 Unaudited Financial Results For Quarter & Nine Months Ended December 31 2025. View
2026-01-19 Announcement under Regulation 30 (LODR)-Press Release / Media Release View
2026-01-17 Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation View
2026-01-09 Disclosure Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 View
2026-01-08 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 View